Pressroom

Featured News​

E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as exclusive financial advisor in connection with a $5.5 million financing for Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc.

E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as exclusive financial advisor in the strategic business combination between Glucotrack, Inc. (Nasdaq: GCTK) and Lōkahi Therapeutics

E.F. Hutton & Co. Advises VCI Global on $6.87 Million Warrant Exercise at Premium to Market

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as financial advisor to VCI Global Limited (Nasdaq: VCIG) (“VCI Global”), an AI-native operating platform designed to scale and optimize businesses through centralized intelligence

EcoModular Appoints E.F. Hutton & Co. as its Exclusive Financial Advisor Ahead of Planned Nasdaq Direct Listing

Appointment positions the volumetric modular AI-native robotic production stack for U.S. public markets as EcoModular scales against a robust, significant pipeline.

recent transactions

Contact Us

Your needs are important to us. Take a moment to complete the form, and we'll make sure to contact you as soon as possible.

    Multi-Level Sidebar